T. Rowe Price Associates’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-63,047
| Closed | -$398K | – | 2982 |
|
|
2022
Q4 | $398K | Hold |
63,047
| – | – | ﹤0.01% | 2243 |
|
|
2022
Q3 | $323K | Sell |
63,047
-546,607
| -90% | -$2.8M | ﹤0.01% | 2341 |
|
|
2022
Q2 | $3.82M | Sell |
609,654
-179,936
| -23% | -$1.13M | ﹤0.01% | 1457 |
|
|
2022
Q1 | $2.8M | Sell |
789,590
-68,505
| -8% | -$243K | ﹤0.01% | 1580 |
|
|
2021
Q4 | $4.31M | Buy |
858,095
+34,713
| +4% | +$174K | ﹤0.01% | 1514 |
|
|
2021
Q3 | $6.03M | Sell |
823,382
-4,346
| -0.5% | -$31.8K | ﹤0.01% | 1490 |
|
|
2021
Q2 | $7.11M | Buy |
+827,728
| New | +$7.11M | ﹤0.01% | 1457 |
|